PMID- 11310845 OWN - NLM STAT- MEDLINE DCOM- 20010517 LR - 20181130 IS - 0741-5400 (Print) IS - 0741-5400 (Linking) VI - 69 IP - 4 DP - 2001 Apr TI - Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice. PG - 590-7 AB - Macrophage-dependent antitumoral activity is partly mediated by soluble factors including cytokines, reactive-oxygen intermediates (ROIs), and reactive-nitrogen intermediates (RNIs). Activation of macrophages for tumor cytotoxicity can be achieved with various bacterial compounds, such as lipopolysaccharides (LPSs), muramyl-dipeptides, and lipopeptides. We studied the production and release of oxygen radicals, nitric oxide, and tumor necrosis factor alpha (TNF-alpha) by bone marrow-derived macrophages (BMDMs) of different mouse inbred strains after they were stimulated with the lipopeptide P3CSK4, a water-soluble synthetic analogue of the lipidated N terminus of bacterial lipoprotein. The lipopeptide was able to induce a strong, long lasting release of oxygen radicals in BALB/c mouse macrophages. Furthermore, it induced nitric oxide release from BMDMs of several mouse strains (BALB/c, C57Bl/6, C57Bl/10ScSn, Sv129, NMRI, and LPS-nonresponder C57Bl/10ScCr). Stimulation with P3CSK4 also resulted in comparable production of TNF-alpha in LPS-responder and nonresponder BMDMs from C57Bl/10ScSn mice and C57Bl/10ScCr mice, respectively. All three antitumoral mediators reached functional levels or concentrations as shown by the strong cytostatic/cytotoxic activity of lipopeptide-activated macrophages for the cell lines Abelson 8-1, M12.5/P815, and L929, which are sensitive to ROIs, nitric oxide, and TNF-alpha, respectively. We found that synthetic lipopeptides can induce the secretion of effective levels of soluble tumor-cytotoxic/cytostatic mediators in BMDMs of LPS-responsive and, of particular interest, also of LPS-unresponsive mice. This result could indicate that the highly effective bacterial-macrophage activators P3CSK4 and LPS use different receptors and/or different intracellular signal transduction pathways. FAU - Pfannes, S D AU - Pfannes SD AD - Institut fur Molekulare Medizin und Zellforschung, AG Tumorimmunologie und Vakzineforschung, Medizinische Fakultat der Universitat Freiburg, Germany. pfannes@uni-freiburg.de FAU - Muller, B AU - Muller B FAU - Korner, S AU - Korner S FAU - Bessler, W G AU - Bessler WG FAU - Hoffmann, P AU - Hoffmann P LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Leukoc Biol JT - Journal of leukocyte biology JID - 8405628 RN - 0 (Acridines) RN - 0 (Free Radicals) RN - 0 (Lipopolysaccharides) RN - 0 (Lipoproteins) RN - 0 (Reactive Oxygen Species) RN - 0 (Tumor Necrosis Factor-alpha) RN - 112208-00-1 (N-palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysine) RN - 2315-97-1 (10,10'-dimethyl-9,9'-biacridinium) RN - 31C4KY9ESH (Nitric Oxide) RN - 9010-72-4 (Zymosan) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.13.39 (Nos2 protein, mouse) SB - IM MH - Acridines/pharmacology MH - Animals MH - Bone Marrow Cells/drug effects MH - Cytotoxicity, Immunologic MH - Drug Resistance MH - Enzyme Induction MH - Female MH - Free Radicals MH - Lipopolysaccharides/*pharmacology MH - Lipoproteins/*pharmacology MH - Luminescent Measurements MH - Lymphoma, B-Cell/pathology MH - Macrophage Activation/drug effects MH - Macrophages/*drug effects/metabolism MH - Male MH - Mast-Cell Sarcoma/pathology MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Nitric Oxide/biosynthesis/*metabolism MH - Nitric Oxide Synthase/biosynthesis MH - Nitric Oxide Synthase Type II MH - Reactive Oxygen Species/*metabolism MH - Respiratory Burst/drug effects MH - Signal Transduction/drug effects MH - Tumor Cells, Cultured MH - Tumor Necrosis Factor-alpha/biosynthesis/*metabolism MH - Zymosan/pharmacology EDAT- 2001/04/20 10:00 MHDA- 2001/05/18 10:01 CRDT- 2001/04/20 10:00 PHST- 2001/04/20 10:00 [pubmed] PHST- 2001/05/18 10:01 [medline] PHST- 2001/04/20 10:00 [entrez] PST - ppublish SO - J Leukoc Biol. 2001 Apr;69(4):590-7.